View Author
imaging 18 f-fch uptake kidney study 99 mtc-mag 3 f-fch injection 68 ga-amba mtc-mag 111 in-dtpa ga-amba tumour cancer mtc-dmsa j nucl med activity therapy prostate tumour uptake choline in-dtpa lysine 99 mtc-dmsa peptide receptor radionuclide function biodistribution animal tissue prostate cancer result 99 mtc-dmsa uptake fi ltration renography radioactivity group 177 lu-dota-tyr 3-octreotate tail vein injection control tracers analogue 99 mtc-dmsa scintigraphy metabolism-based krenning ep patient spect ltration tracer organ scintigraphy 30 min damage 177 lu tubules bladder medicine • vol scanning model serum quanti background tumours small-animal 68 gaamba bombesin netherland 50 mbq jong m prrt rats 20 min medicine 11 c-choline ef flux somatostatin c-choline 99 mtc-dmsa imaging camera pc -3 tumours
2 Most Recent Publications
|
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
(Article)
Schroeder, R.P.J. Weerden, W.M. van Jong, M. de Krenning, E.P. Bangma, C.H. Berndsen, S.C. Grievink-De Ligt, C.H. Groen, H.C. Reneman, S. Blois, E. de Breeman, W.A.P. |
2011-07-01
|
|
Dynamic and static small-animal SPECT in rats for monitoring renal function after177Lu-labeled Tyr3-octreotate radionuclide therapy
(Article)
Melis, M.L. Swart, J. de Visser, M. de Berndsen, S.C. Koelewijn, S. Valkema, R. Boerman, O.C. Krenning, E.P. Jong, M. de |
2010-12-01
|
